novo nordisk semaglutide pill medicines containing Novo Nordisk's Ozempic Sister Drug

If you are starting or currently taking a GLP-1 medication, we encourage you to reach out and schedule an appointment so we can establish a monitoring plan that fits your needs

By harnessing the combined power of nature and scientific research, this innovative supplement offers a nature-based alternative to GLP-1 agonists, focusing on gut health and overall well-being

Comprehensive Support Beyond diet and exercise, we focus on your overall well-being

Once a medication is FDA-approved for any condition, licensed physicians can prescribe it for other conditions if they believe it will benefit the patient

Similarly, in the propensity score adjusted post hoc results, there were no significant differences in the semaglutide QW adherence at day 180 or day 360 (63.3% and 63.4%, respectively) compared with dulaglutide adherence (66.7% [ p = 0.32] and 52.3% [ p = 0.20], respectively) (Table 2)